Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1708 ARTÍCULOS , VIENDO DEL 1051 AL 1065

Regional mitochondrial DNA and cell-type changes in post-mortem brains of non-diabetic Alzheimer's disease are not present in diabetic Alzheimer's disease

Thubron EB, Rosa HS, Hodges A, Sivaprasad S, Francis PT, Pienaar IS, Malik AN.

Sci Rep. 2019 Aug 6;9(1):11386. doi: 10.1038/s41598-019-47783-4.

The determinants of cognitive decline and dementia

Brayne C, Matthews FE.

BMJ. 2019 Aug 7;366:l4946. doi: 10.1136/bmj.l4946.

Diagnostic evaluation and monitoring of patients with posterior cortical atrophy

Wong B, Lucente DE, MacLean J, Padmanabhan J, Quimby M, Brandt KD, Putcha D, Sherman J, Frosch MP, McGinnis S, Dickerson BC.

Neurodegener Dis Manag. 2019 Aug;9(4):217-239. doi: 10.2217/nmt-2018-0052. Epub 2019 Aug 8.

Prospects and challenges of imaging neuroinflammation beyond TSPO in Alzheimer's disease

Boche D, Gerhard A, Rodriguez-Vieitez E; MINC Faculty.

Eur J Nucl Med Mol Imaging. 2019 Dec;46(13):2831-2847. doi: 10.1007/s00259-019-04462-w. Epub 2019 Aug 8.

Adaptation of the DEMQOL-Proxy for routine use in care homes: a cross-sectional study of the reliability and validity of DEMQOL-CH

Hughes LJ, Farina N, Page TE, Tabet N, Banerjee S.

BMJ Open. 2019 Aug 8;9(8):e028045. doi: 10.1136/bmjopen-2018-028045.

Pain assessment in impaired cognition: observer agreement in a long-term care setting in patients with dementia

van Dalen-Kok AH, Achterberg WP, Rijkmans WE, de Vet HC, de Waal MW.

Pain Manag. 2019 Sep;9(5):461-473. doi: 10.2217/pmt-2019-0025. Epub 2019 Aug 12.

(18)F-FDG PET, the early phases and the delivery rate of (18)F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against (15)O-H(2)O PET

Ottoy J, Verhaeghe J, Niemantsverdriet E, De Roeck E, Wyffels L, Ceyssens S, Van Broeckhoven C, Engelborghs S, Stroobants S, Staelens S.

Alzheimers Dement. 2019 Sep;15(9):1172-1182. doi: 10.1016/j.jalz.2019.05.010. Epub 2019 Aug 9.

Oscillatory connectivity as a diagnostic marker of dementia due to Alzheimer's disease

Musaeus CS, Engedal K, Høgh P, Jelic V, Mørup M, Naik M, Oeksengaard AR, Snaedal J, Wahlund LO, Waldemar G, Andersen BB.

Clin Neurophysiol. 2019 Oct;130(10):1889-1899. doi: 10.1016/j.clinph.2019.07.016. Epub 2019 Jul 29.

Is Reaction Time Slowing an Early Sign of Alzheimer's Disease? A Meta-Analysis

Andriuta D, Diouf M, Roussel M, Godefroy O.

Dement Geriatr Cogn Disord. 2019;47(4-6):281-288. doi: 10.1159/000500348. Epub 2019 Aug 13.

Investigation of base excision repair gene variants in late-onset Alzheimer's disease

Ertuzun T, Semerci A, Cakir ME, Ekmekcioglu A, Gok MO, Soltys DT, de Souza-Pinto NC, Sezerman U, Muftuoglu M.

PLoS One. 2019 Aug 15;14(8):e0221362. doi: 10.1371/journal.pone.0221362. eCollection 2019.

[Innovation in diagnostics-mobile technologies]

Düzel E, Thyrian JR, Berron D.

Nervenarzt. 2019 Sep;90(9):914-920. doi: 10.1007/s00115-019-0773-8.

Souvenaid in the management of mild cognitive impairment: an expert consensus opinion

Cummings J, Passmore P, McGuinness B, Mok V, Chen C, Engelborghs S, Woodward M, Manzano S, Garcia-Ribas G, Cappa S, Bertolucci P, Chu LW.

Alzheimers Res Ther. 2019 Aug 17;11(1):73. doi: 10.1186/s13195-019-0528-6.

Misdiagnosis leads to Iatrogenesis

Chin AV.

Med J Malaysia. 2019 Aug;74(4):359-362.

Alzheimer's dementia: pathogenesis and impact of cardiovascular risk factors on cognitive decline

Wanleenuwat P, Iwanowski P, Kozubski W.

Postgrad Med. 2019 Sep;131(7):415-422. doi: 10.1080/00325481.2019.1657776. Epub 2019 Aug 27.

Modifiable Risk Factors Explain Socioeconomic Inequalities in Dementia Risk: Evidence from a Population-Based Prospective Cohort Study

Deckers K, Cadar D, van Boxtel MPJ, Verhey FRJ, Steptoe A, Köhler S.

J Alzheimers Dis. 2019;71(2):549-557. doi: 10.3233/JAD-190541.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias